What is the current Price Target for the NRX Pharmaceuticals Inc stock?

The average NRX Pharmaceuticals Inc target price is $28.50. This is 925.18% higher than the current stock price. The highest price target is 1,554.68%, the lowest is 547.48%. 4 Analysts have issued a price target NRX Pharmaceuticals Inc 2026 .

How high will the NRX Pharmaceuticals Inc stock rise?

No reliable answer can be given as to how high the NRX Pharmaceuticals Inc stock will rise. The performance of stocks, including the NRX Pharmaceuticals Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the NRX Pharmaceuticals Inc stock today?

The performance of NRX Pharmaceuticals Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the NRX Pharmaceuticals Inc stock fall?

The decline in NRX Pharmaceuticals Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

NRX Pharmaceuticals Inc Forecast, price target & analysts

$2.63

5.40% today

Nasdaq, May 21, 09:17 pm CET

ISIN

US6294441000

Symbol

NRXP

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

NRX Pharmaceuticals Inc Target price 2025 - Analyst rating & recommendation

NRX Pharmaceuticals Inc Classifications & Recommendation:

Buy

100%

NRX Pharmaceuticals Inc Price Target

Target Price	$28.50
Price	$2.78
Potential	925.18% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target NRX Pharmaceuticals Inc 2026 . The average NRX Pharmaceuticals Inc target price is $28.50. This is 925.18% register free of charge higher than the current stock price. The highest price target is $46.00 1,554.68% register free of charge , the lowest is $18.00 547.48% register free of charge .
	A rating was issued by 4 analysts: 4 Analysts recommend NRX Pharmaceuticals Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the NRX Pharmaceuticals Inc stock has an average upside potential 2026 of 925.18% register free of charge . Most analysts recommend the NRX Pharmaceuticals Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-2.36	0.01
	490.00%	100.42%
P/E		556.00
EV/Sales		0.97

2 Analysts have issued a NRX Pharmaceuticals Inc forecast for earnings per share. The average NRX Pharmaceuticals Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-2.36	490.00%
2025	$0.01 100.42% Unlock
2026	$0.80 7,900.00% Unlock
2027	$2.72 240.00% Unlock
2028	$5.92 117.65% Unlock
2029	$11.60 95.95% Unlock

Current	-1.38	12.66%
2025	556.00 40,389.86% Unlock
2026	3.50 99.37% Unlock
2027	1.02 70.86% Unlock
2028	0.47 53.92% Unlock
2029	0.24 48.94% Unlock

NRX Pharmaceuticals Inc...

Current NRX Pharmaceuticals Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
D. Boral Capital	Locked ➜ Locked	Locked	May 16 2025
D. Boral Capital	Locked ➜ Locked	Locked	Apr 30 2025
Ascendiant Capital	Locked ➜ Locked	Locked	Apr 29 2025
BTIG	Locked ➜ Locked	Locked	Apr 02 2025
D. Boral Capital	Locked ➜ Locked	Locked	Mar 31 2025
D. Boral Capital	Locked ➜ Locked	Locked	Mar 24 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 20 2025

Analyst Rating	Date
Locked D. Boral Capital: Locked ➜ Locked	May 16 2025
Locked D. Boral Capital: Locked ➜ Locked	Apr 30 2025
Locked Ascendiant Capital: Locked ➜ Locked	Apr 29 2025
Locked BTIG: Locked ➜ Locked	Apr 02 2025
Locked D. Boral Capital: Locked ➜ Locked	Mar 31 2025
Locked D. Boral Capital: Locked ➜ Locked	Mar 24 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 20 2025

Discover more stocks with a high price target

BioNTech SE - ADR 32.27%

Alibaba Group Holding Ltd 28.43%

Tencent Holdings Ltd. 21.98%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now